+44(0)20 7638 9271

Monthly Archives: April 2018

Druces advises Summit Therapeutics PLC on £15M fundraising

City-based law firm, Druces, has advised AIM and NASDAQ-listed Summit Therapeutics PLC on its £15.0m fundraising. Summit raised the additional capital through an issue of 8,333,333 new ordinary shares (before expenses) whereby the proceeds will be used to:  accelerate preparatory activities for a placebo controlled clinical trial of the utrophin modulator ezutromid in patients with […]

Read more >